VBI Vaccines (VBIV) Short Interest Ratio & Short Volume → The #1 Crypto That You Don’t Own… Yet (From Crypto 101 Media) (Ad) Free VBIV Stock Alerts $0.61 +0.01 (+1.66%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends VBI Vaccines Short Interest DataCurrent Short Interest302,500 sharesPrevious Short Interest372,800 sharesChange Vs. Previous Month-18.86%Dollar Volume Sold Short$198,742.50Short Interest Ratio0.7 Days to CoverLast Record DateMay 15, 2024Outstanding Shares28,680,000 sharesFloat Size25,690,000 sharesShort Percent of Float1.18%Today's Trading Volume41,724 sharesAverage Trading Volume111,742 sharesToday's Volume Vs. Average37% Short Selling VBI Vaccines ? Sign up to receive the latest short interest report for VBI Vaccines and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVBIV Short Interest Over TimeVBIV Days to Cover Over TimeVBIV Percentage of Float Shorted Over Time Ad Behind the MarketsDon’t buy a single NVIDIA share before you see this...If you feel like NVIDIA is still a good buy - be careful. Billionaires like Steve Cohen, Stanley Druckenmiller and George Soros are ALL dumping NVIDIA... And piling into an overlooked sector...I've prepared a short briefing with all the proof VBI Vaccines Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/2024302,500 shares $198,742.50 -18.9%1.2%0.7 $0.66 4/30/2024372,800 shares $212,868.80 -47.5%1.4%0.8 $0.57 4/15/2024709,500 shares $411,510.00 +145.4%2.7%1.6 $0.58 3/31/2024289,100 shares $174,211.66 -4.6%1.3%0.8 $0.60 3/15/2024302,900 shares $169,836.03 -3.4%1.4%2.4 $0.56 2/29/2024313,500 shares $181,830.00 -15.7%1.4%2.4 $0.58 Get the Latest News and Ratings for VBIV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VBI Vaccines and its competitors with MarketBeat's FREE daily newsletter. 2/15/2024371,700 shares $223,057.17 +20.4%1.7%2.7 $0.60 1/31/2024308,800 shares $216,160.00 +7.0%1.4%2.8 $0.70 1/15/2024288,700 shares $176,135.87 -3.8%1.3%2.5 $0.61 12/31/2023300,200 shares $176,367.50 +0.1%1.4%2.5 $0.59 12/15/2023300,000 shares $186,900.00 +11.9%1.4%1.9 $0.62 11/30/2023268,100 shares $164,935.12 -42.1%1.2%1.4 $0.62 11/15/2023463,000 shares $287,986.00 +107.2%2.1%2.2 $0.62 10/31/2023223,500 shares $131,887.35 -20.2%1.0%1.1 $0.59 10/15/2023280,100 shares $156,856.00 -36.9%1.3%1.2 $0.56 9/30/2023443,900 shares $295,726.18 +161.7%2.1%1.1 $0.67 9/15/2023169,600 shares $186,560.00 +28.5%0.8%0.1 $1.10 8/31/2023132,000 shares $161,040.00 -15.6%0.6%0.1 $1.22 8/15/2023156,300 shares $200,064.00 -35.8%0.7%0.1 $1.28 7/31/2023243,600 shares $319,116.00 -39.4%1.1%0.2 $1.31 7/15/2023402,000 shares $534,660.00 +66.4%5.4%0.3 $1.33 6/30/2023241,600 shares $794,864.00 -49.8%3.0%0.2 $3.29 6/15/2023481,300 shares $1.24 million -10.0%5.9%3.7 $2.58 5/31/2023534,500 shares $1.59 million -5.2%6.6%4.9 $2.97 5/15/2023564,000 shares $1.74 million +8.4%7.0%5.5 $3.09 4/30/2023520,200 shares $1.49 million -1.4%6.4%5.4 $2.87 4/15/2023527,700 shares $1.69 million -0.9%6.5%6.5 $3.20 3/31/2023532,200 shares $3.23 million -96.5%6.6%9.7 $6.06 3/15/202315,050,000 shares $5.00 million +8.7%6.2%16.2 $0.33 2/28/202313,840,000 shares $6.64 million +3.0%5.7%14.7 $0.48 2/15/202313,440,000 shares $7.34 million +4.1%5.5%13.4 $0.55 1/31/202312,910,000 shares $7.51 million +7.0%5.3%12.5 $0.58 1/15/202312,070,000 shares $6.70 million +1.9%5.0%12.2 $0.56 12/30/202211,850,000 shares $4.63 million -1.6%4.9%12.5 $0.39 12/15/202212,040,000 shares $5.90 million -6.4%4.9%14.5 $0.49 11/30/202212,860,000 shares $6.69 million -6.3%5.3%14.7 $0.52 11/15/202213,730,000 shares $9.39 million +3.9%5.6%16.7 $0.68 10/31/202213,210,000 shares $9.51 million -5.2%5.4%14.8 $0.72 10/15/202213,930,000 shares $9.14 million -1.1%5.7%14 $0.66 9/30/202214,090,000 shares $9.94 million -4.0%5.8%11.5 $0.71The #1 Crypto That You Don’t Own… Yet (Ad)There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details… 9/15/202214,670,000 shares $12.07 million +3.1%6.0%10.3 $0.82 8/31/202214,230,000 shares $12.74 million -4.6%5.8%6.8 $0.90 8/15/202214,920,000 shares $19.84 million -10.4%6.1%6.7 $1.33 7/31/202216,660,000 shares $14.17 million +0.9%6.8%6.8 $0.85 7/15/202216,510,000 shares $13.43 million -0.1%6.8%6.5 $0.81 6/30/202216,520,000 shares $13.36 million -23.7%6.8%6.7 $0.81 6/15/202221,660,000 shares $15.79 million +5.9%8.9%8.3 $0.73 5/31/202220,450,000 shares $18.71 million +6.7%8.4%10 $0.92 5/15/202219,160,000 shares $20.69 million +7.8%7.9%9.2 $1.08 4/30/202217,780,000 shares $22.23 million +0.2%7.3%8.9 $1.25 4/15/202217,750,000 shares $27.51 million +2.1%7.3%8.3 $1.55 3/31/202217,390,000 shares $28.87 million -0.2%7.1%7.4 $1.66 3/15/202217,430,000 shares $24.40 million -1.0%7.2%7.4 $1.40 2/28/202217,600,000 shares $26.22 million -2.4%7.3%6.5 $1.49 2/15/202218,040,000 shares $28.14 million +1.7%7.4%4.9 $1.56 1/31/202217,740,000 shares $30.16 million +11.9%7.3%4.8 $1.70 1/15/202215,860,000 shares $32.51 million +4.4%6.5%4.4 $2.05 12/31/202115,190,000 shares $35.54 million -19.4%N/A4.5 $2.34 12/15/202118,840,000 shares $45.59 million -7.3%7.8%5.8 $2.42 11/30/202120,320,000 shares $61.77 million -2.3%8.4%6.5 $3.04 11/15/202120,790,000 shares $61.54 million +2.4%8.6%9.8 $2.96 10/29/202120,300,000 shares $58.87 million +2.4%8.4%10 $2.90 10/15/202119,830,000 shares $59.89 million -2.7%8.2%9.9 $3.02 9/30/202120,380,000 shares $63.38 million -11.3%8.4%9.7 $3.11 9/15/202122,970,000 shares $72.59 million -8.2%9.5%9.5 $3.16 8/31/202125,010,000 shares $90.29 million -11.7%10.4%9 $3.61 8/13/202128,320,000 shares $81.84 million +0.4%11.7%9.9 $2.89 7/30/202128,220,000 shares $84.10 million +7.4%11.7%9.3 $2.98 7/15/202126,270,000 shares $77.50 million -3.6%11.0%8.1 $2.95 6/30/202127,260,000 shares $91.32 million -18.8%11.4%8 $3.35 6/15/202133,560,000 shares $131.56 million -4.7%14.0%9.9 $3.92 5/28/202135,220,000 shares $113.76 million -8.8%14.7%10 $3.23 5/14/202138,610,000 shares $104.63 million +2.4%16.1%9.6 $2.71 4/30/202137,710,000 shares $120.67 million -4.1%15.7%7.5 $3.20 4/15/202139,330,000 shares $113.66 million +2.1%16.9%6.4 $2.89 3/31/202138,520,000 shares $113.63 million -11.5%16.7%5.6 $2.95 3/15/202143,540,000 shares $140.63 million +6.7%18.8%5.8 $3.23 2/26/202140,820,000 shares $133.89 million +3.3%17.6%5.4 $3.28 2/12/202139,530,000 shares $160.49 million -6.2%17.9%5.1 $4.06 1/29/202142,130,000 shares $137.34 million -5.8%19.1%5.4 $3.26 1/15/202144,740,000 shares $144.06 million No Change20.3%6.5 $3.22 1/15/20206,510,000 shares $11.85 million -20.0%N/A1.2 $1.82 12/31/20198,140,000 shares $11.15 million +84.6%N/A1.7 $1.37 9/30/20193,510,000 shares $1.67 million -23.0%4.4%2.4 $0.48 VBIV Short Interest - Frequently Asked Questions What is VBI Vaccines' current short interest? Short interest is the volume of VBI Vaccines shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 302,500 shares of VBIV short. 1.18% of VBI Vaccines' shares are currently sold short. Learn More on VBI Vaccines' current short interest. What is a good short interest ratio for VBI Vaccines? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VBIV shares currently have a short interest ratio of 1.0. Learn More on VBI Vaccines's short interest ratio. What is a good short interest percentage for VBI Vaccines? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.18% of VBI Vaccines' floating shares are currently sold short. Is VBI Vaccines' short interest increasing or decreasing? VBI Vaccines saw a decrease in short interest in May. As of May 15th, there was short interest totaling 302,500 shares, a decrease of 18.9% from the previous total of 372,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is VBI Vaccines' float size? VBI Vaccines currently has issued a total of 28,680,000 shares. Some of VBI Vaccines' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. VBI Vaccines currently has a public float of 25,690,000 shares. How does VBI Vaccines' short interest compare to its competitors? 1.18% of VBI Vaccines' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to VBI Vaccines: Tempest Therapeutics, Inc. (9.61%), Journey Medical Co. (2.94%), Landos Biopharma, Inc. (0.05%), Genelux Co. (12.10%), Eledon Pharmaceuticals, Inc. (0.77%), BioXcel Therapeutics, Inc. (4.34%), Lantern Pharma Inc. (5.50%), Celularity Inc. (5.94%), MediciNova, Inc. (0.34%), Checkpoint Therapeutics, Inc. (12.68%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short VBI Vaccines stock? Short selling VBIV is an investing strategy that aims to generate trading profit from VBI Vaccines as its price is falling. VBIV shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against VBI Vaccines? A short squeeze for VBI Vaccines occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VBIV, which in turn drives the price of the stock up even further. How often is VBI Vaccines' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VBIV, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: TPST Short Interest DERM Short Interest LABP Short Interest GNLX Short Interest ELDN Short Interest BTAI Short Interest LTRN Short Interest CELU Short Interest MNOV Short Interest CKPT Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VBIV) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlace“Financial tsunami is coming to America”Porter & CompanyNvidia is about to pass AppleWeiss RatingsUnlock Explosive Gains with This Defense StockBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VBI Vaccines Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.